Harnessing AI in the Specialty Chemicals Industry
Signals One unifies and structures data to be AI-ready. Our automation allows AI and machine-learning tools analyze data so that scientists can focus on innovation.

Signals One unifies and structures data to be AI-ready. Our automation allows AI and machine-learning tools analyze data so that scientists can focus on innovation.
Learn about techniques such as Protacs and molecular glues. Explore Revvity's blog for more insights about how researchers are targeting the undruggable
Signals Image Artist is an advanced image analysis software for high-content screening and cell imaging data. Analyze, visualize and share your results with ease.
Pharmaceutical and biotechnology companies face many changes if the Biosecure Act passes into law. Learn how Revvity Signals solutions, such as Signals Synergy can aid the biotechnology sector.
Read on more about the collaboration between Revvity Signals and TetraScience. See how this partnership can facilitate faster and better scientific decision-making.
In 2024, Signals ChemDraw, Signals Clinical and Signals Synergy launched. Read how Revvity Signals supports new modalities in drug discovery and research development.
Revvity introduces groundbreaking Phenologic.AI software at SLAS 2025, transforming cellular imaging workflows and showcasing innovative life sciences solutions for drug discovery and development.
Discover Signals Synergy, the most comprehensive solution designed to enhance collaboration, project management, and data exchange between sponsors and CROs.
AI boosts brightfield imaging for fast, label-free cell analysis.